Qiagen N.V. (QGEN) Fundamentals

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%).
SHARE INFORMATION
Market Cap$ 11,316,391,800
Shares Outstanding227,694,000
Float192,082,035
Percent Float84.36%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 2,251,657,000
Latest Fiscal EPS$ 2.22
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions1,144
Institutional Holdings Date2021-03-31
Institutional Bought Previous 3 Months19,996,412
Institutional Holdings Percent132.5%
Institutional Sold Previous 3 Months71,597,678
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 58.00
52 Week Low$ 41.32
52 Week High Change$ -5.80
21 Day Moving Average$ 48.1114
21 Day Extended Moving Average$ 48.4329
50 Day Moving Average$ 46.805
50 Day Extended Moving Average$ 47.4558
200 Day Moving Average$ 49.3377
200 Day Extended Moving Average$ 48.3562
10 Day Average Volume1,011,137
20 Day Average Volume979,207
30 Day Average Volume1,078,068
50 Day Average Volume984,059
Alpha0.007268
Beta0.3045
Standard Deviation0.086187
R20.031219
7 Day Price Change$ 0.06
7 Day Percent Change0.12%
21 Day Price Change$ 2.74
21 Day Percent Change5.83%
30 Day Price Change$ 1.38
30 Day Percent Change2.86%
Month to Date Price Change$ 0.06
Month to Date Percent Change0.12%
Quarter to Date Price Change$ 2.50
Quarter to Date Percent Change5.3%
180 Day Price Change$ -0.07
180 Day Percent Change-0.14%
200 Day Price Change$ 1.22
200 Day Percent Change2.52%
Year to Date Price Change$ -5.88
Year to Date Percent Change-10.58%

Qiagen N.V. (QGEN) Key Ratios

PROFITABILITY
EBIT Margin30.2%
EBITDA Margin39.4%
Pre-Tax Profit Margin14.0%
Profit Margin Count22.68%
Gross Margin64.4%
Profit Margin TOT22.68%
INCOME STATEMENTS
Revenue$ 2,261,046,000
Revenue Per Share$ 9.9302
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book32.60
Total Debt To Equity0.60
Int Coverage12.60
Current Ratio2.20
Leverage Ratio1.90
Quick Ratio1.70
Long Term Debt To Capital0.31
VALUATION MEASURES
PE Ratio22.40
Enterprise Value$ 11,940,950,800
Price to Sales5.0049
Price to Free Cash23.20
PE High Last 5 Years222.20
Price To Book3.50
Price To Cash Flow15.70
PE Low Last 5 Years-174.80
Price to Tangible Book32.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.70
Invoice Turnover2.00
Assets Turnover0.40
Return Assets9.04
Return on Equity17.39
Return on Capital10.35

Qiagen N.V. (QGEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG AG Wirtschaftspruefungsgesellschaft
CEOThierry Bernard
Emplyoees6100
Last AuditUE
CIK0001015820
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSResearch and Development in the Social Sciences and Humanities(541720)
CONTACT INFO
AddressHulsterweg 82
Venlo, 5912 PL
Websitehttps://www.qiagen.com
Facsimile+31 773556658
Telephone+31 773556600
Emailsarah.fakih@qiagen.com


Your Recent History
NYSE
QGEN
Qiagen NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.